GLP-1 Analogues. Unintended Consequence: Big Food Finally Blinks by Patrick Holmes

The £400 Monthly Question 💊
2.5 million UK adults are buying weight loss drugs privately. The real story? They're accidentally forcing the food industry to reform after decades of failed government attempts.

What's Actually Happening 📊
US data shows 12% of adults using GLP-1 drugs. The market response:
🔹 Household food spending down 8.6%
🔹 Sharpest drops in ultra-processed foods
🔹 Fresh produce and protein stable
🔹 Fast food spending down 8%
🔹 $12bn potential loss for snack food sector
Nestlé, General Mills and Walmart are reformulating products.
Greggs now offers smaller, protein-rich portions.
The Fat Duck created a specific menu for GLP-1 users.

Decades of voluntary reformulation targets achieved little. Market forces are now doing what regulation couldn't.

The Growing Divide ⚠️
Facts: 64% of UK adults overweight or obese.
NHS coverage minimal.
NICE limits use to two years.
Weight typically returns after stopping.

The Rt. Hon. Wes Streeting MP called it correctly: health determined by wealth. Those who can afford private prescriptions get healthier. Those who can't remain stuck with the same toxic food environment.

A Rare Alignment 🎯
For once, consumer health interests, industry profits and government goals point the same way. The government's new "healthy food standard" shows recognition, but bolder action is needed before this window closes.
Without intervention, food companies will simply redirect unhealthy food marketing to lower-income groups who can't access these medications.

Three Realities 💡
1️⃣ Treating individuals with expensive drugs whilst 64% remain at risk isn't public health policy
2️⃣ Every month we delay systemic change deepens the health gap between rich and poor
3️⃣ The food industry will adapt regardless. Question is whether government shapes this for public benefit or lets markets serve only the wealthy

The Actual Opportunity 🚀
GLP-1 drugs provide economic proof that food companies will reformulate when profits depend on it.
Government faces a choice: use this moment to enforce real food system change, or watch health inequality become permanent.
These drugs aren't solving obesity. They're revealing that we've always had the power to fix our food environment. We just lacked the will.
Medicating two-thirds of the population isn't success. It's system failure.

Read the original post here.